MOESM6 of Characterization of tenascin-C as a novel biomarker for asthma: utility of tenascin-C in combination with periostin or immunoglobulin E

Additional file 6: Table S6. Omalizumab-treated patients to divide into 4 groups according to serum TNC and Periostin levels.